Evaluation of the Compatibility of Moxifloxacin with Selected Excipients Used in the Formulation of Nanopharmaceuticals
- 11 February 2022
- journal article
- research article
- Published by Springer Nature in Pharmaceutical Chemistry Journal
- Vol. 55 (11) , 1184-1189
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Nanomaterial Based Approaches for the Diagnosis and Therapy of Cardiovascular DiseasesCurrent Pharmaceutical Design, 2015
- Lubricants in Pharmaceutical Solid Dosage FormsLubricants, 2014
- Drug–excipient compatibility screening—Role of thermoanalytical and spectroscopic techniquesJournal of Pharmaceutical and Biomedical Analysis, 2014
- Compatibility studies of nateglinide with excipients in immediate release tabletsActa Pharmaceutica, 2011
- Solid state compatibility studies with tablet excipients using non thermal methodsJournal of Pharmaceutical and Biomedical Analysis, 2011
- Injectable biodegradable temperature-responsive PLGA–PEG–PLGA copolymers: Synthesis and effect of copolymer composition on the drug release from the copolymer-based hydrogelsInternational Journal of Pharmaceutics, 2005
- Recent advances on chitosan-based micro- and nanoparticles in drug deliveryJournal of Controlled Release, 2004
- Rapid, practical and predictive excipient compatibility screening using isothermal microcalorimetryThermochimica Acta, 2001
- Use of Chitosan in Compressed Tablets of Diclofenac Sodium: Inhibition of Drug Release in an Acidic EnvironmentPharmaceutical Development and Technology, 1997
- Effect of Inert Tablet Ingredients on Drug Absorption IJournal of Pharmaceutical Sciences, 1966